NCT00485225View on ClinicalTrials.gov

Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

July 31, 2008

Conditions
Chronic, Non Malignant Pain
Interventions
DRUG

EN3270

Transdermal Therapeutic System

Trial Locations (1)

08009

Comprehensive Clinical Research, Berlin

Sponsors

Lead Sponsor

Durect
All Listed Sponsors
lead

Durect

INDUSTRY

NCT00485225 - Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain | Biotech Hunter | Biotech Hunter